Healthcare
Demeter et al. invest €5.3m in Fermentalg
A consortium of investors led by Demeter Partners has provided French biotechnology company Fermentalg with a €5.3m round of funding.
Leonardo Ventures exits Isis and Culavis
Leonardo Ventures has sold its two of it portfolio companies Isis sentronics and Culavis forfor for €1.6m and €45,000 respectively to private investors.
ProA buys Ambuibérica in all-equity deal
Spanish private equity firm ProA Capital has acquired an 85% stake in ambulance company Grupo Ambuibérica as part of an all-equity deal.
BDC backs C2S MBO
Bridgepoint Development Capital has acquired a 51% stake in French clinics operator Compagnie Stéphanoise de Santé (C2S) for an undisclosed amount.
Investinor et al. inject NOK 25m in Smartfish
Investinor has led a NOK 25m investment in Smartfish, a Norwegian biotech company that offers synergistic omega-3 based emulsions.
Ysios et al. invest €18m in Cellerix
Existing investors have invested a further €18m in Spanish biopharma Cellerix, prior to its merger with Belgium-based TiGenix.
Bridgepoint acquires Médipôle Sud Santé
Bridgepoint Capital has acquired French clinics operator Médipôle Sud Santé for an undisclosed amount.
AC Desarrollo-backed Geroresidencias-La Saleta acquires Secopsaleta
Geroresidencias-La Saleta, a portfolio company of AC Desarrollo, has acquired 100% of Secopsaleta, the business it co-founded in 2009.
EQT-owned Gambro sells CaridianBCT
EQT and Investor-backed Gambro AB has sold CaridianBCT to Terumo Corporation for an enterprise value of $2.625bn.
Consortium sells LAB901
Archangel Informal Investment, Alliance Trust, Scottish Enterprise, Foresight, Noble Fund Managers and the Business Growth Fund have exited their stake in LAB901.
SLS Invest and SEB sell Sanos
SLS Invest and SEB have sold their stakes in Danish biotech company Sanos Bioscience A/S to Nordic Bioscience A/S.
Life Sciences Partners backs Activaero
Venture Capital firm Life Sciences Partners has lead a series-A finance round for Activaero with €3.5m.
Alven Capital et al. invest €3m in Happyview.fr
Alven Capital and a consortium of private investors have provided French online optician Happyview.fr with €3m of growth capital funding.
Inveready backs Transbiomed
Venture capital firm Inveready Seed Capital has invested $1.2m in a first round of finance in biotechnology company Transbiomed.
Realza-backed Plénida acquires 80% of Buccal
Grupo Plénida, a portfolio company of Realza Capital, has acquired an 80% stake in dental chain Buccal.
SEED Capital invests in Medichanical
SEED Capital has invested in Danish medical equipment company Medichanical Engineering ApS.
HTGF exits Kinaxo
HTGF has sold its portfolio company Kinaxo to pharmaceutical company Evotec AG for €3m and 2,597.400 shares in the new parent.
CIC LBO Partners et al. acquire AMS
CIC LBO Partners and CM-CIC Capital Privé have acquired French healthcare provider AMS from Capazanine for an undisclosed amount.
Consortium invests SEK 10m in Promimic
A consortium, consisting of ALMI Invest, Karolinska Development and several business angels among others, has injected SEK 10m in Gothenburg-based Promimic AB.
Ventizz exits Medos Medizintechnik
Private equity firm Ventizz Capital Partners has sold its 100% stake in German medical equipment provider Medos Medizintechnik AG to venture firm Zukunftsfonds Heilbronn GmbH & Co KG.
Altor sells Ferrosan to Pfizer
Altor has sold Danish consumer health company Ferrosan Consumer Health (FCH) to Pfizer Inc.
123Venture invests €11m in Philogeris Residences
123Venture has invested €11m in French retirement homes operator Philogeris Residences.
XAnge and EPF invest €4m in Clinique Développement
XAnge Private Equity and EPF Partners have invested €4m in French clinics operator Clinique Développement.
NBGI Private Equity invests in Sante
NBGI Private Equity has acquired a majority stake in Turkish operator of oncology therapy centres Sante Group for an undisclosed amount.